Form D · Other Technology
Halcyon Health, Inc.
New York, NY · CIK 0001803552
Offering snapshot reported Feb 19, 2020 · SEC filing
- Reported sold
- $2.5M Offering amount: $2.5M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 4, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 19, 2020 | Initial | $2,500,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-360869
Source: Form D, filed Feb 19, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Bryk | Director, Executive, Promoter |
| Joshua Nussbaum | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
Spaces, Halcyon Health 9 Th Floor 127 West 30 Th Street
New York, NY, 10001
New York, NY, 10001